Alnylam Pharmaceuticals, Inc. (ALNY)
146.37
-1.45
(-0.98%)
USD |
NASDAQ |
Nov 20, 14:52
Alnylam Pharmaceuticals 30-Day Average Daily Volume : 2.712M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.712M |
| November 18, 2026 | 2.699M |
| November 17, 2026 | 2.651M |
| November 16, 2026 | 2.628M |
| November 13, 2026 | 2.598M |
| November 12, 2026 | 2.534M |
| November 11, 2026 | 2.484M |
| November 10, 2026 | 2.407M |
| November 09, 2026 | 2.351M |
| November 06, 2026 | 2.279M |
| November 05, 2026 | 2.221M |
| November 04, 2026 | 2.142M |
| November 03, 2026 | 2.070M |
| November 02, 2026 | 1.981M |
| October 30, 2026 | 1.861M |
| October 29, 2026 | 1.717M |
| October 28, 2026 | 1.358M |
| October 27, 2026 | 1.321M |
| October 26, 2026 | 1.340M |
| October 23, 2026 | 1.326M |
| October 22, 2026 | 1.330M |
| October 21, 2026 | 1.310M |
| October 20, 2026 | 1.318M |
| October 19, 2026 | 1.335M |
| October 16, 2026 | 1.338M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.348M |
| October 14, 2026 | 1.416M |
| October 13, 2026 | 1.444M |
| October 12, 2026 | 1.461M |
| October 09, 2026 | 1.492M |
| October 08, 2026 | 1.503M |
| October 07, 2026 | 1.481M |
| October 06, 2026 | 1.498M |
| October 05, 2026 | 1.524M |
| October 02, 2026 | 1.545M |
| October 01, 2026 | 1.546M |
| September 30, 2026 | 1.542M |
| September 29, 2026 | 1.560M |
| September 28, 2026 | 1.585M |
| September 25, 2026 | 1.598M |
| September 24, 2026 | 1.610M |
| September 23, 2026 | 1.633M |
| September 22, 2026 | 1.632M |
| September 21, 2026 | 1.641M |
| September 18, 2026 | 1.660M |
| September 17, 2026 | 1.644M |
| September 16, 2026 | 1.702M |
| September 15, 2026 | 1.777M |
| September 14, 2026 | 1.818M |
| September 11, 2026 | 1.934M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Ionis Pharmaceuticals, Inc. | 4.128M |
| Vertex Pharmaceuticals, Inc. | 1.518M |
| Pfizer Inc. | 34.09M |
| Regeneron Pharmaceuticals, Inc. | 910037.9 |
| BridgeBio Pharma, Inc. | 2.799M |